These studies suggested that MAT2A is required for cancer cell growth and proliferation, and targeting the methionine-MAT2A-SAM axis through MAT2A inhibition could be a novel and promising strategy for cancer therapy [20,21]. This evidence concerns the gene MAT2A and cancer.